STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. Show more

Location: 25510 Commercentre Drive, Lake Forest, CA, 92630, United States | Website: https://www.staar.com | Industry: Medical Instruments & Supplies | Sector: Healthcare


Market Cap

860.8M

52 Wk Range

$13.50 - $46.79

Previous Close

$17.81

Open

$17.67

Volume

372,893

Day Range

$17.14 - $17.68

Enterprise Value

644.7M

Cash

222.8M

Avg Qtr Burn

-2.922M

Insider Ownership

0.64%

Institutional Own.

-

Qtr Updated

03/28/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date